TVGN · Tevogen Inc. · Executive Compensation
Market Cap
$47.92M
Shares
6.51M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ryan Saadi | M.D., M.P.H. Chief Executive Officer | $10,421,000 |
| Kirti Desai | Chief Financial Officer | $1,230,000 |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $722,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ryan Saadi | M.D., M.P.H. Chief Executive Officer | $87,764,783 |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $350,000 |
| Kirti Desai | Chief Financial Officer | $300,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $2,926,000 |
| Ryan Saadi | M.D., M.P.H. Chief Executive Officer | $501,000 |
| Kirti Desai | Chief Financial Officer | $300,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Victor Sordillo | Class II director | Appointed | 2026-08-26 |
| Dr. Keow Lin Goh | Class II director | Appointed | 2026-08-26 |
| Suren Ajjarapu | director | Resigned | 2024-08-23 |